Deliverables
Report on the implementation of D1.2 co-led by IRD and SP
Communication of a detailed stakeholder map for the DRIVE projectDeliverable co-led by THL and SEQIRUS
Methodology guidelines for concerted analysis of data and control of confounding factorsThis report will be led by P95 together ABBOT. It will be submmitted in M4 and updated on M55.
Final report on governance and principlesThis deliverables will be coled by IRD and SP Final report on governance and principles
Final DMPFinal update of D42
First seasonal final report of conducted studiesFinal report on the analysis of the seasonal results to be produced annually
Fifth seasonal final report of conducted studiesFinal report on the analysis of the seasonal results to be produced annually
Report on the brand availability and usage of specific influenza vaccine brandsThis report will be co-led by ISS and SEQIRUS, submmited in M12 and periodically updated.
Report of the results of a systematic analysis on existing initiatives, tools, and/or study protocols for determining IVE […]Lead participants of this report will be FISABIO and GSK.
Communication report of the study milestones arising from WP7 for the use of “layer 1” stakeholdersThis deliverable will have periodic updates on M30, 42 and 60.
Report on synergies identified and collaborations developed with other initiativesThis deliverable will be updated on M60.
Report templatesThis report will be led by P95 and ABBOT, submmitted in M8 periodically updated in M15, M27, M39 and M59.
Project assessmentMid-Term DMP
Mid-term update of D4.2
Guideline for the identification of vaccine status and vaccine used in study participantsThis deliverable will be co-led by FISABIO and GSK. It will be submmitted in M16 and will have periodic updates.
Second seasonal final report of conducted studiesFinal report on the analysis of the seasonal results to be produced annually
Third seasonal final report of conducted studiesFinal report on the analysis of the seasonal results to be produced annually
Report with the definition of the ethics policies handbooks collectionThis deliverable will be co-led by FISABIO and SYNAPSE
Generic SAPThis deliverables will be led by P95 and ABBOT.
Project HandbookEvaluation reports of how the vaccine effectiveness results could fulfil the new regulatory requirements
The lead beneficiaries of this deliverable will be IABS-EU and SEQIRUS. It will be delivered in M15 and annually updated.
Generic post authorisation development plan on effectiveness of vaccinesThis deliverable sill be coled by IRD and SP Generic post authorisation development plan on effectiveness of vaccines
SWOT analysis plan and list of quality criteriaThis deliverable will be co-led by ISS and SEQIRUS
Annual tender for influenza vaccine effectiveness study conductThis report will be led by FISABIO and GSK, submmitted in M16 and updated on M28 and M40
Report on feasible novel and innovative approaches for measuring influenza VEThis deliverable will have periodic updates
Standard Operating Procedures (SOPs) and templatesDeliverables co-led by SURREY and GSK. It will be submmited in month 8 and annually updated.
Written report on quality and feasibility evaluationThis deliverables will be led by ISS and SEQIRUS. It will be submmitted in M14 and periodically updated.
Tailored, timely seasonal summaries of VE results for different stakeholder/clients in layer 1 and 2This deliverable will have periodic updates on M20, 30, 42, 60.
Multi Stake-holder Research AgendaThis deliverable will be co-led by IRD and SP. It will be submmitted in M10 and annually updated.
Updated protocol for type- and brand- specific influenza vaccine effectiveness studies (population-based database studies)This deliverable will have periodic updates on M11, M23 and M35.
Agreement on communications governance modelDeliverable co-led by THL and SEQIRUS
Periodical back-to-back Forum of key stakeholders […]Deliverable co-led by THL and IABS-EU. It will be reviewed annually after its submmission in M14.
Development of the communications planDeliverable co-led by THL and SEQIRUS. It will be submmitted in M12 and will have periodic updates.
Fourth seasonal final report of conducted studiesFinal report on the analysis of the seasonal results to be produced annually
Web-based survey amongst layer 1 stakeholdersCo-led by THL and SEQIRUS.
Updated and developed protocol for type- and brand- specific IVESThis report will have periodic updates on M11, M23 and M35
Report on the comparison of adapted local protocols and Ethical Committee evaluation in each study siteThis report will be led by UNIFI and SEQIRUS, submmited in M12 and it will have periodic updates
Final Report and Sustainability PlanThis report will be led by FISABIO with the collaboration of all WPLs since it will summarize all updates lessons learned and further improvements made in the regular updates of the deliverables linked to the sustainability plan
Report on the sources for usage of specific influenza vaccine brands and accessibilityThis report will be led by P95 and SEQIRUS, submmitted in M6 and periodically updated
Report on the collected feed-back from “layer 1” […]Report co-led by THL and SEQIRUS. It will be submmited in M14 and will have periodic updates.
Governance Standard Operating Procedures (SOP)This report will be co-led by IRD and SP. It will be submmitted in M3
Generic DMPThis deliverables will be co-led by P95 and ABBOT. It will be submmitted in M6 and updated on M30 and M60 (separate deliverables).
Report on feasibility study for influenza virus characterization, molecular epidemiology studies related to influenza related disease in vaccinated and unvaccinated subjectsPoints to consider document on the interpretation of VE results
This report will also be co-led by P95 and ABBOT, submmitted in M12 annually updated.
Lead participants of this delivable will also be FISABIO and GSK
IT infrastructure to receive and analyse the dataThis deliverables will be led by P95.
Publications
Author(s):
Anke L. Stuurman, Jorne Biccler, Antonio Carmona, Alexandre Descamps, Javier Díez-Domingo, Cintia Muñoz Quiles, Hanna Nohynek, Caterina Rizzo, Margarita Riera-Montes
Published in:
Vaccine, Issue 39/29, 2021, Page(s) 3964-3973, ISSN 0264-410X
Publisher:
Elsevier BV
DOI:
10.1016/j.vaccine.2021.05.059
Author(s):
Simon de Lusignan, Uy Hoang, Harshana Liyanage, Manasa Tripathy, Julian Sherlock, Mark Joy, Filipa Ferreira, Javier Diez-Domingo, Tristan Clark
Published in:
PLOS ONE, Issue 16/3, 2021, Page(s) e0248123, ISSN 1932-6203
Publisher:
Public Library of Science
DOI:
10.1371/journal.pone.0248123
Author(s):
Anke L. Stuurman, Caterina Rizzo, Mendel Haag
Published in:
PLOS ONE, Issue 16/4, 2021, Page(s) e0248943, ISSN 1932-6203
Publisher:
Public Library of Science
DOI:
10.1371/journal.pone.0248943
Author(s):
Anke L. Stuurman, Kaatje Bollaerts, Maria Alexandridou, Jorne Biccler, Javier Díez Domingo, Hanna Nohynek, Caterina Rizzo, Topi Turunen, Margarita Riera-Montes
Published in:
Vaccine, Issue 38/41, 2020, Page(s) 6455-6463, ISSN 0264-410X
Publisher:
Elsevier BV
DOI:
10.1016/j.vaccine.2020.07.063
Author(s):
Antonio Carmona, Cintia Muñoz-Quiles, Anke Stuurman, Alexandre Descamps, Ainara Mira-Iglesias, Laurence Torcel-Pagnon, Javier Díez-Domingo
Published in:
International Journal of Environmental Research and Public Health, Issue 18/3, 2021, Page(s) 1058, ISSN 1660-4601
Publisher:
MDPI
DOI:
10.3390/ijerph18031058
Author(s):
Anke L. Stuurman, Sara Ciampini, Alfredo Vannacci, Antonino Bella, Caterina Rizzo, Cintia Muñoz-Quiles, Elisabetta Pandolfi, Harshana Liyanage, Mendel Haag, Monika Redlberger-Fritz, Roberto Bonaiuti, Philippe Beutels
Published in:
PLOS ONE, Issue 16/6, 2021, Page(s) e0252836, ISSN 1932-6203
Publisher:
Public Library of Science
DOI:
10.1371/journal.pone.0252836
Author(s):
Ulrike Baum, Sangita Kulathinal, Kari Auranen, Hanna Nohynek
Published in:
Clinical Infectious Diseases, 2020, ISSN 1058-4838
Publisher:
University of Chicago Press
DOI:
10.1093/cid/ciaa050
Author(s):
Donatella Panatto, Piero Luigi Lai, Stefano Mosca, Elvina Lecini, Andrea Orsi, Alessio Signori, Silvana Castaldi, Elena Pariani, Laura Pellegrinelli, Cristina Galli, Giovanni Anselmi, Giancarlo Icardi
Published in:
Vaccines, Issue 8/1, 2020, Page(s) 119, ISSN 2076-393X
Publisher:
Multidisciplinary Digital Publishing Institute (MDPI)
DOI:
10.3390/vaccines8010119
Author(s):
Simon de Lusignan, Uy Hoang, Harshana Liyanage, Manasa Tripathy, Ivelina Yonova, Rachel Byford, Filipa Ferreira, Javier Diez-Domingo, Tristan Clark
Published in:
British Journal of General Practice, 2020, Page(s) bjgp20X710897, ISSN 0960-1643
Publisher:
Royal College of General Practitioners
DOI:
10.3399/bjgp20x710897
Author(s):
Caterina Rizzo, Francesco Gesualdo, Daniela Loconsole, Elisabetta Pandolfi, Antonino Bella, Andrea Orsi, Giulia Guarona, Donatella Panatto, Giancarlo Icardi, Christian Napoli, Giovanni Battista Orsi, Ilaria Manini, Emanuele Montomoli, Ilaria Campagna, Luisa Russo, Valeria Alfonsi, Simona Puzelli, Antonino Reale, Umberto Raucci, Livia Piccioni, Carlo Concato, Marta Luisa Ciofi Degli Atti, Alberto V
Published in:
Vaccines, Issue 8/3, 2020, Page(s) 427, ISSN 2076-393X
Publisher:
Multidisciplinary Digital Publishing Institute (MDPI)
DOI:
10.3390/vaccines8030427
Author(s):
Raija Auvinen, Hanna Nohynek, Ritva Syrjänen, Jukka Ollgren, Tuija Kerttula, Jarkko Mäntylä, Niina Ikonen, Raisa Loginov, Anu Haveri, Satu Kurkela, Kirsi Skogberg
Published in:
MedRxiv, 2020, ISSN 0000-0000
Publisher:
Cold Spring Harbor Laboratory
DOI:
10.1101/2020.06.29.20140632
Searching for OpenAIRE data...
There was an error trying to search data from OpenAIRE
No results available